Financials

  • Market Capitalization 913.81 M
  • Employee 239
  • Founded 2021
  • CEO N/A
  • Website www.alumis.com
  • Headquarter Delaware, United States
  • FIGI BBG01J7X4PN2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.41
Rapporto prezzo/fatturato
34.51

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2418
ANRO
Alto Neuroscience, Inc. Common Stock
24.15 USD-0.74%+2.07%-24.53%+321.47%947.70 M USD
2426
KURA
Kura Oncology, Inc. - Common Stock
10.40 USD-1.89%-3.26%-8.53%+4.73%925.19 M USD
2436
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
48.81 USD-0.55%+1.31%+3.15%+62.00%911.76 M USD
2440
MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares
10.68 USD-1.29%-7.13%-14.97%+11.72%908.94 M USD